Literature DB >> 10668081

[Sickle cell disease in children in Dakar, Senegal].

I Diagne1, O Ndiaye, C Moreira, H Signate-Sy, B Camara, S Diouf, A Diack-Mbaye, M Ba, M Sarr, D Sow, M Fall.   

Abstract

AIM OF THE STUDY: To determine the socioeconomic, clinical and biological aspects of sickle cell disease (SCD) in Senegalese children and adolescents, we retrospectively analysed all records of follow-up attending patients in the Albert Royer Children Hospital of Dakar (Senegal).
RESULTS: Homozygous sickle cell (SS) was the most frequent genotype (307 cases). Sickle cell hemoglobin C (13 cases) and sickle cell beta-thalassemia (three cases) were uncommon. Patients were aged from five months to 22 years (mean age: eight years). Most of them came from poor families. The mean number of children was five in patients' families, with at least two cases of SCD in 60% of them. Immunization against hepatitis B virus (10.2%), Haemophilus influenzae b (8.4%), Salmonella (8.7%) and Streptococcus pneumoniae (21.4%) was insufficiently performed, because of its relatively high cost. Only 30% of the patients had received a blood transfusion. Painful crises occurred less than three times a year in 74% of the cases. Complications such as acute chest syndrome (1%), stroke (1%), cholelithiasis (9%), meningitis (0.4%), septicemia (2%) and osteomyelitis (6%) were rare. Mean steady state hemoglobin (Hb) and hemoglobin F(HbF) levels were 8.27 +/- 1.36 g/dL and 6.8 +/- 5.9% respectively among SS patients. No correlations were found neither between Hb and HbF nor between these parameters and the frequency of complications. Eleven patients (1.1% per year of follow-up) died, and infection was the main cause of death (73%).
CONCLUSION: In comparison with published data, SCD seems to have mild severity in Senegalese children and adolescents in spite of poor follow-up conditions. In addition to genetic factors, environmental factors might have an important role in disease tolerance.

Entities:  

Mesh:

Year:  2000        PMID: 10668081     DOI: 10.1016/s0929-693x(00)88912-5

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  10 in total

1.  Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.

Authors:  Chung-Jen Chen; Sabrina Bakeera-Kitaka; Ezekiel Mupere; Philip Kasirye; Deogratias Munube; Richard Idro; Heather Hume; Betsy Pfeffer; Philip LaRussa; Nancy S Green
Journal:  J Paediatr Child Health       Date:  2018-11-09       Impact factor: 1.954

2.  Profile of Patients with Gallstone Disease in a Sub-Saharan African General Surgery Department: A Retrospective Cohort Study Protocol.

Authors:  A Ndong; N F Gaye; J N Tendeng; M L Diao; A C Diallo; F G Niang; S Diop; D A Dia; M Diedhiou; M Dieng; M L Fall; P M Ma Nyemb; I Konaté
Journal:  Int J Surg Protoc       Date:  2021-04-27

Review 3.  Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.

Authors:  Amy Geard; Gift D Pule; David Chelo; Valentina Josiane Ngo Bitoungui; Ambroise Wonkam
Journal:  OMICS       Date:  2016-10

4.  GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study.

Authors:  Mani Ramzi; Aliraza Rezvani; Mehdi Dehghani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-01-01

5.  [Sickle cell disease in stationary phase in 6-59 months children in Lubumbashi: epidemiology and clinical features].

Authors:  Mick Ya Pongombo Shongo; Olivier Mukuku; Toni Kasole Lubala; Augustin Mulangu Mutombo; Gray Wakamb Kanteng; Winnie Sombodi Umumbu; Robert Mbuli Lukamba; Stanislas Okitotsho Wembonyama; Oscar Numbi Luboya
Journal:  Pan Afr Med J       Date:  2014-09-24

6.  Erythrocyte indices in Pre-school Nigerian Children with Sickle Cell Anaemia in Steady State.

Authors:  Samuel Olufemi Akodu; Olisamedua Fidelis Njokanma; Omolara AdeoluKehinde
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-01-01

7.  [Evaluation of hemogram in patients with homozygous sickle cell disease: about 87 cases].

Authors:  Fatima Dahmani; Souad Benkirane; Jaafar Kouzih; Aziz Woumki; Hassan Mamad; Azlarab Masrar
Journal:  Pan Afr Med J       Date:  2016-12-20

8.  Serum homocysteine and disease severity in sickle cell anemia patients in Lagos.

Authors:  Ebele Uche; Oluwaseun Adelekan; Akinsegun Akinbami; Vincent Osunkalu; Kamal Ismail; Ann Abiola Ogbenna; Mulikat Badiru; Adedoyin Dosunmu; Esther Oluwole; Omolara Kamson
Journal:  J Blood Med       Date:  2019-05-08

9.  An observational study of children with sickle cell disease in Kilifi, Kenya.

Authors:  Manish Sadarangani; Julie Makani; Albert N Komba; Tolu Ajala-Agbo; Charles R Newton; Kevin Marsh; Thomas N Williams
Journal:  Br J Haematol       Date:  2009-07-23       Impact factor: 6.998

10.  [Epidemiological, clinical and hematological profiles of homozygous sickle cell disease during the intercritical period among children in Ziguinchor, Senegal].

Authors:  Lamine Thiam; Assane Dramé; Isabelle Zokébé Coly; François Niokhor Diouf; Ndiogou Seck; Djibril Boiro; Aliou Abdoulaye Ndongo; Idrissa Basse; Babacar Niang; Indou Deme/Ly; Assane Sylla; Ibrahima Diagne; Ousmane Ndiaye
Journal:  Pan Afr Med J       Date:  2017-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.